ROYAL BANK OF CANADA - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 10 filers reported holding INHIBIKASE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$12,000
-65.7%
2,000
-60.0%
0.00%
Q4 2020$35,0005,0000.00%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 1,076,500$1,593,0001.68%
Lynwood Capital Management Inc. 120,000$178,0000.19%
Retirement Planning Co of New England, Inc. 116,402$172,0000.10%
Kepos Capital LP 700,000$1,036,0000.08%
HAMILTON LANE ADVISORS LLC 165,635$245,0000.06%
Redmond Asset Management, LLC 122,682$182,0000.05%
SABBY MANAGEMENT, LLC 99,000$147,0000.02%
Antara Capital LP 303,000$448,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$139,0000.01%
Shay Capital LLC 20,000$30,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders